cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS at 37ºC in an atmosphere containing 5% CO2.
Cell viability assay: DU145 cells were seeded at a density of 2.5 x 10 5 per 100 μL onto 96well plates and incubated overnight, then assayed by sulphorhodamineB stain ing. Absorbance was measured at 570 nm using an ELISA reader.
Cell cycle analysis: Propidium iodide staining (cycle test plus DNA reagent kit, BD Biosciences) was used for the analysis of cell cycle distribution according to manual protocol. The cells were then examined by flow cytometry (FACScan, BD Biosciences).
Western blot analysis:
The cells were lysed in 20 μL loading buffer (20% glycerol, 2% SDS, 125 mM Tris pH 6.8, 5% βmercaptoethanol, bromophenol blue) follow ed by incubation for 5 min at 95ºC. The 816% precise protein gel (Fisher Scientific, Schwerte, Germany) was used for the separation. The proteins were transferred onto PVDF membranes (GE Healthcare, Freiburg, Ger many) and incubated with primary antibodies against GAPDH, p21 and cyclin D1 Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). β-actin (SigmaAldrich, St. Louis, MO, USA) was used as loading control. The secondary polyclonal rabbit antimouse immunoglobu lin or the polyclonal swine antirabbit immunoglobulin HRPlinked antibody and the enhanced chemilumi nescence kit (GE Healthcare) were used for visua lization.
Flow cytometric assessment of cell death using annexin V/PI assay: The annexin VFITC apoptosis detection kit (BD Bioscience, San Jose, CA, USA) was used to measure apoptosis in DU145 cell lines. The cells were incubated at a density of 2.5 x 10 5 cells/well for 24 hours followed by treatment with escopoletin for 48 hours. After treatment the cells were washed with PBS and then suspended in 100 μL binding buffer. Incubation of cells with 3 μL annexin VFITC (BD Bioscience) was follow ed by addition of 10 μL propidium iodide (BD Biosci ence) at room temperature for 15 min. Flow cytometry (BectonDickinson, San Jose, CA, USA) was used to determine the fluorescent intensities.
Intracellular ROS assays:
A 5 μM nonfluorescent probe, 2',7'dichlorofluoresceindiacetate (DCFH-DA) was used for the detection of formation of ROS. The flow cytometry (FC500) was used to measure the fluores cence generated for oxidation of DCFH.
Statistical analysis:
The MedCalc version 10.0 program (Frank Schoonjans, University of Gent, Belgium) was employed for the statistical analyses. The Mann Whitney Utest, analysis of variance, and the Kruskal Wallis tests were used. The differences were considered statistically significant at p value <0.05.
Results

Escopoletin suppresses proliferation of DU145 cells:
Investi gation of the effect of escopoletin on DU145 cell sensi tivity revealed inhibitory effect after 24 hours ( Figure  1 ). The inhibitory effect of escopoletin was found to be dose dependent with maximum inhibition at 20 μM after 24 hours. Although the inhibition of cell viability started at 5 μM concentration of escopoletin but the effect was significant at 20 μM.
Escopoletin induces non-apoptotic cell death in DU145 cells:
The results from flow cytometry showed an increase in the percentage of propidium iodide stained cells with increase in concentration of escopoletin from 5 to 20 μM. The proportion of propidium iodide stained cells was found to be 1.7, 19.6, 25.8 and 58.5%, respectively at 0, 5, 10 and 20 μM after 24 hours of the treatment (Figure 2 ). However, there was no change in the 
Escopoletin induces generation of ROS in DU145 cells:
Exposure of DU145 cells to 20 μM escopoletin for 24 hours markedly enhanced the concentration of intra cellular ROS (DCFH) compared to the untreated control cells. The level of ROS in DU145 cells was enhanced by 9fold compared to untreated cells. However, the effect of escopoletin on DU145 cells was reversed in the cells pretreated with glutathione (GSH) antioxidant ( Figure  3 ). This suggests that escopoletin induced generation of ROS is responsible for the increased cytotoxicity in DU145 cells.
Escopoletin regulates cell cycle in DU145 cells:
The results from flow cytometry showed that escopoletin treatment at a dose of 20 μM for 24 hours resulted G1 cell cycle arrest, decreased population of cells in the S and G2/M phases without any effect on subG1 cell population ( Figure 3A) . The cell cycle arrest of DU145 cells by escopoletin was found to be dose dependent. Exposure of DU145 cells to 10 and 20 μM of escopoletin caused accumulation of 54.6 and 79.5% cells, respectively in the population of cells in G1 phase. Western blot analysis revealed enhanced expression of G1 phase marker, the cyclin D1 protein at a concentration of 20 μM escopole tin in DU145 cells ( Figure 3B) .
Discussion
In the current study effect of escopoletin was investiga ted against prostate cancer cells. The results revealed that escopoletin inhibited the viability of DU145 cells in a dose dependent manner. It caused accumulation of cells in the G1 phase of cellcycle and did not induce apoptosis. Analysis of the presence G1 phase marker in DU145 cells showed significantly higher concentration (Abbas and Dutta, 2009 ). The results from our study revealed that escopoletin induces arrest of cellcycle in G1 phase through the involvement of p21. The flow cytometry showed an increase in the percentage of propidium iodide stained cells with increase in concentration of escopoletin. The ratio of nonapoptotic cell death in the annexin V/ propidium iodide doublestaining assay was consistent with the sulphorhodamineB cell viability induced by escopoletin treatment. The results also revealed that no significant early apoptosis was caused by escopoletin. It has been observed in the primary rat cortical neurons that a reduction in the level of GSH is dependent on the enhancement in oxidative stress (Hood et al., 2010) . Generation of ROS has been observed before the onset of cell death and its increased generation in necrosis is responsible for cell death (Di Stefano et al., 2006) . Our results showed that escopoletin treatment resulted in the generation of ROS which in turn induced non apoptotic cell death in DU145 cells. However, exposure of DU145 cells to GSH reversed the anticancer effect induced by escopoletin. This suggests that escopoletin exhibits its effect on prostate cancer cells through production of ROS. The present study demonstrates that escopoletin treatment can be potential anticancer agent against prostate cancer. 
